Prevalence and comorbidities of dry eye disease in eye clinic in Japan

Prevalence and comorbidities of dry eye disease in eye clinic in Japan - Prevalence and comorbidities of dry eye disease in eye clinic in Japan

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000035506

Enrollment

1000

Registered

2019-01-15

Start date

2019-01-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Corneal and conjunctival fluorescein staining score

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 20 years of age or over Regardless of sex

Exclusion criteria

Exclusion criteria: Subjects who cannot confirm subjective symptoms of dry eye Subjects with hypersensitivity to fluorescein Subjects who cannot perform fluorescein staining Subjects who were judged ineligible by an investigator of this study.

Design outcomes

Primary

Measure	Time frame
Dry eye prevalence in patients visited the study site. Dry eye merger rate every other eye disease.	—

Countries

Japan

Contacts

Public ContactYoshiaki Yamada

Santen Pharmaceutical Co., Ltd. Japan Medical Affairs, Development Management Department, Japan Business

clinical@santen.co.jp06-4802-9603

Outcome results